Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation EuroPCR 2025

Angiography versus physiology-guided PCI in patients undergoing TAVI: the functional assessment in TAVI (FAITAVI) trial

Presenter: Flavio Ribichini

May 22, 2025

Presentation EuroPCR 2024

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Presenter: Frederik Zimmermann

May 15, 2024

Presentation EuroPCR 2022

The ROLEX Study(Revascularization Of LEft main with resolute onyX): A prospective, international, multicenter study of left main PCI with a zotarolimus-eluting stent

Presenter: Giuseppe Tarantini

May 31, 2022

Presentation EuroPCR 2019

Contemporary bifurcation treatment practice: what we can learn from a large global registry

Presenter: Bernard Chevalier

May 21, 2019

Presentation EuroPCR 2018

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

Presenter: Panagiotis Xaplanteris

May 23, 2018

Presentation EuroPCR 2018

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

Presenter: Frederik M. Zimmermann

May 23, 2018

Presentation EuroPCR 2018

PCI Statement on PCI Treatment for Chronic Coronary Syndrome

Presenter: Michael Haude

May 22, 2018

Presentation EuroPCR 2015

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

Presenter: Ota Hlinomaz

May 19, 2015

$Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial$

Presentation EuroPCR 2014

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Presenter: Uwe Zeymer

May 21, 2014

Presentation EuroPCR 2012

CompariSon of Manual Aspiration with Rheolytic Thrombectomy in Acute Myocardial Infarction: the SMART Primary PCI Trial

Presenter: David Antoniucci

May 16, 2012

Advertisement

Angiography versus physiology-guided PCI in patients undergoing TAVI: the functional assessment in TAVI (FAITAVI) trial

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

The ROLEX Study(Revascularization Of LEft main with resolute onyX): A prospective, international, multicenter study of left main PCI with a zotarolimus-eluting stent

Contemporary bifurcation treatment practice: what we can learn from a large global registry

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

PCI Statement on PCI Treatment for Chronic Coronary Syndrome

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

CompariSon of Manual Aspiration with Rheolytic Thrombectomy in Acute Myocardial Infarction: the SMART Primary PCI Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content